| Academic Research Enhancement Award for Undergraduate-Focused Institutions (R15 Clinical Trial Not Allowed)- PAR-21-155 |
R15
|
May 19, 2021 |
May 08, 2024 |
| Administrative Supplement for Research on Dietary Supplements (Admin Supp, Clinical Trial Not Allowed)- PA-20-227 |
Supp
|
June 09, 2020 |
April 16, 2023 |
| Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)- PA-20-272 |
Supp
|
October 13, 2020 |
July 24, 2023 |
| Administrative Supplements To Promote Diversity in Research and Development Small Businesses-SBIR/STTR (Admin Supp Clinical Trial Not Allowed)- PA-21-345 |
Supp
|
September 10, 2021 |
September 10, 2024 |
| Asthma and Allergic Diseases Cooperative Research Centers (U19 Clinical Trial Optional)- RFA-AI-21-079 |
U19
|
December 23, 2021 |
June 04, 2022 |
| Biomarker Signatures of TB Infection in Young Children With and Without HIV (R01 Clinical Trial Not Allowed)- RFA-AI-22-015 |
R01
|
February 09, 2022 |
June 09, 2022 |
| Biomedical Data Repository (U24 Clinical Trials Not Allowed)- PAR-20-089 |
U24
|
January 17, 2020 |
May 09, 2023 |
| Biomedical Knowledgebase (U24 Clinical Trials Not Allowed)- PAR-20-097 |
U24
|
January 17, 2020 |
May 09, 2023 |
| CCRP Initiative—Chemical Threat Agent-induced Pulmonary and Ocular Pathophysiological Mechanisms (R01 Clinical Trial Not Allowed)- RFA-ES-21-006 |
R01
|
June 25, 2021 |
September 21, 2023 |
| Centers for AIDS Research (P30 Clinical Trial Not Allowed)- PAR-20-106 |
P30
|
February 03, 2020 |
July 29, 2022 |
| Change of Recipient Organization (Type 7 Parent Clinical Trial Optional)- PA-21-268 |
|
June 30, 2021 |
July 01, 2024 |
| Countermeasures Against Chemical Threats (CounterACT) Exploratory/Developmental Projects (R21 Clinical Trial Not Allowed)- PAR-20-253 |
R21
|
July 07, 2020 |
May 31, 2023 |
| Countermeasures Against Chemical Threats (CounterACT) Research Centers of Excellence (U54 Clinical Trial Optional)- PAR-20-316 |
U54
|
December 21, 2020 |
September 13, 2023 |
| Data Management and Coordinating Center (DMCC) for the Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Collaborative Research Centers (CRC) (U24 Basic Experimental Studies with Humans Required)- RFA-NS-22-020 |
U24
|
February 15, 2022 |
May 25, 2022 |
| Detection of HIV for Self-Testing (R61/R33 Clinical Trial Not Allowed)- PAR-21-070 |
R61/R33
|
November 13, 2020 |
March 18, 2023 |
| Development and Optimization of Next-Generation Immunological Assays to Support Influenza Clinical Studies and Trials (UH2/UH3 Clinical Trial Not Allowed)- RFA-AI-22-020 |
UH2/UH3
|
April 05, 2022 |
July 02, 2022 |
| Development of HIV Broadly Neutralizing Antibody Susceptibility Assays (R61/R33 Clinical Trial Not Allowed)- RFA-AI-22-022 |
R61/R33
|
March 10, 2022 |
August 04, 2022 |
| Development of the Fetal Immune System (R01 Clinical Trial Not Allowed)- PAR-20-298 |
R01
|
September 09, 2020 |
December 08, 2023 |
| Developmental Centers for AIDS Research (P30 Clinical Trial Not Allowed)- PAR-20-107 |
P30
|
February 03, 2020 |
July 29, 2022 |
| Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)- PAR-22-105 |
R01
|
May 10, 2022 |
May 08, 2025 |
| Dissemination and Implementation Research in Health (R21 Clinical Trial Optional)- PAR-22-109 |
R21
|
May 10, 2022 |
May 08, 2025 |
| Early Stage Investigator Research Using Nonhuman Primate (NHP) Models (R21 Clinical Trial Not Allowed)- PAR-21-109 |
R21
|
January 11, 2021 |
May 08, 2024 |
| Early-Stage Development of Data Science Technologies for Infectious and Immune-mediated Diseases (U01 Clinical Trial Not Allowed)- RFA-AI-21-020 |
U01
|
March 17, 2021 |
July 07, 2023 |
| Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement, Clinical Trial Optional)- PA-20-135 |
Supp
|
March 10, 2020 |
September 08, 2025 |
| Enhancing HIV Reservoir Susceptibility to Elimination (R01 Clinical Trial Not Allowed)- RFA-AI-22-025 |
R01
|
March 29, 2022 |
August 04, 2022 |
